# Hillhouse Investment

> Hillhouse Investment is a VC fund backing Manufacturing and Software. See 274 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 274
- Last investment: Jun 2026
- Lead investor: 45%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hillhouse-investment/
- Website: http://www.hillhouseinvestment.com

Hillhouse Investment is a VC fund in Singapore focused on Manufacturing and Software. Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

## Contacts

5 contacts available for Hillhouse Investment. Shizune tracks 10 team members at Hillhouse Investment. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hillhouse-investment?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $8M–$282M |
| Series B | $10M–$200M |
| Series C | $28M–$310M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 23 | 8% |
| Software | 22 | 8% |
| Biotechnology | 22 | 8% |
| Health Care | 18 | 7% |
| Artificial Intelligence | 17 | 6% |

135 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 36 | 13% |
| Series B | 33 | 12% |
| Series C | 22 | 8% |
| Seed | 16 | 6% |
| Series D | 8 | 3% |

12 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 93 | 34% |
| United States | 11 | 4% |
| Singapore | 6 | 2% |
| India | 3 | 1% |
| Japan | 2 | 1% |

11 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Rhee | Partner | 16 | https://shizune.co/investors/profile/david-rhee |
| Michael Yi | Partner | 23 | https://shizune.co/investors/profile/michael-yi |
| Zhang Lei | Chairman, Founder, CEO | 3 | https://shizune.co/investors/profile/zhang-lei-2 |
| Zhang Lei | Chairman, Founder, CEO | 4 | https://shizune.co/investors/profile/zhang-lei |
| Ed Zhang | Venture Partner, HH Bioventure | 0 | https://shizune.co/investors/profile/ed-zhang-65b8 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DayOne | GDS International portfolio currently comprises approximately 480 MW of data center capacity in service and under construction and an additional 590 MW held for future development across strategic locations in Hong Kong, Singapore, Malaysia (Johor), Indonesia (Batam), and Japan (Tokyo). | $2.5B | Series C | Jun 05, 2026 |  |
| LifeLabs Design | LifeLabs Design is a materials science company that develops technology designed to reduce energy consumption. It focuses on developing innovative solutions to society’s most pressing issues: clean energy storage, water purification, thermoregulation, combined with Professor Cui’s background in energy and environmental technologies - from electriccar batteries to wind and solar energy storage to soil filtration - promises a focus on sustainability unprecedented within the textile industry. |  | Angel | May 29, 2026 |  |
| StringMotion Future | StringMotion Future focuses on the core technology research and development of tendon-inspired chord-driven robots, creating advanced robotic systems designed to deliver greater flexibility, precision, and efficiency for industrial and intelligent automation applications. |  | Angel | May 21, 2026 |  |
| Axoft | Axoft develops implantable electronics to amplify brain-machine communication. The company solves BMI by developing soft, scalable, and stable next-generation neural probes, realizing subcellular resolution, ultra-high bandwidth, minimally invasive, and long-term stable brain-machine interface to seamlessly connect the brain to electronics. | $55M | Series A | Apr 29, 2026 |  |
| Nova Fusion | Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors. | $102.5M | Angel | Apr 10, 2026 |  |
| ModMax | ModMax is a forward-thinking developer specializing in intelligent electric all-terrain vehicles, combining advanced engineering, smart technology, and sustainable design to create high-performance machines capable of navigating diverse and challenging terrains with efficiency, safety, and environmental responsibility. |  | Angel | Mar 26, 2026 |  |
| Metanovas Biotech | Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning. |  | Series A | Mar 09, 2026 |  |
| Quest Global | QuEST Global Services is a provider of outsourced engineering services with over 2000 employees and operations across USA, Europe, and Asia.Founded in 1997, QuEST has been a trusted partner providing comprehensive support across the complete engineering lifecycle to help their customers improve efficiency, increase quality, create new products,and open new markets. |  | Private Equity | Feb 23, 2026 |  |
| YMC Semiconductor | YUMEI Semiconductor is a semiconductor equipment company that specializes in semiconductor services. Its primary activities include research and development, production, and sales of specific equipment for semiconductor devices. | $101.3M | Series A | Feb 14, 2026 |  |
| Third Arc Bio | Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pipeline of high-value therapeutics – a solid tumor synergy platform and an I&I platformthat offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. | $52M | Series A | Feb 04, 2026 |  |

10 of 274 investments shown.

## Co-investors
- [Hillhouse Investment](https://shizune.co/investors/profile/hillhouse-capital) — VC Fund, 192 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 24 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 18 deals together
- [Source Code Capital](https://shizune.co/investors/profile/source-code-capital) — VC Fund, 18 deals together
- [GL Ventures](https://shizune.co/investors/profile/gl-ventures) — VC Fund, 17 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 16 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Software Investors in China](https://shizune.co/investors/software-investors-china)
- [Artificial intelligence VC Funds in Asia](https://shizune.co/investors/artificial-intelligence-vc-funds-asia)
- [Artificial intelligence Investors in Asia](https://shizune.co/investors/artificial-intelligence-investors-asia)
- [Artificial intelligence VC Funds in China](https://shizune.co/investors/artificial-intelligence-vc-funds-china)
- [Artificial intelligence Investors in China](https://shizune.co/investors/artificial-intelligence-investors-china)
- [Biotechnology Investors in China](https://shizune.co/investors/biotechnology-investors-china)

## FAQ

### What does Hillhouse Investment invest in?

Hillhouse Investment invests primarily in Manufacturing, Software and Biotechnology startups, most often at Series A and Series B stage. Most of the 274 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Hillhouse Investment's check size?

Hillhouse Investment typically joins rounds of $8M–$282M at Series A, $10M–$200M at Series B and $28M–$310M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Hillhouse Investment participates in.

### How do I contact Hillhouse Investment?

Public channels for Hillhouse Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hillhouse Investment?

The team at Hillhouse Investment includes David Rhee (Partner), Michael Yi (Partner) and Zhang Lei (Chairman, Founder, CEO), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co